Targeted mutation in the Fas gene causes hyperplasia in peripheral lymphoid organs and liver

Nature Genetics

Volumn 11, Issue 3, 1995, Pages 294-300

  Adachi, Masashi ^a   Suematsu, Sachiko ^b   Kondo, Toru ^a   Ogasawara, Jun ^a   Tanaka, Takashi ^b   Yoshida, Nobuaki ^b   Nagata, Shigekazu ^a  

^a OSAKA BIOSCIENCE INSTITUTE   (Japan)

^b RESEARCH INSTITUTE FOR MATERNAL AND CHILD HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DNA FRAGMENT; MEMBRANE PROTEIN; MESSENGER RNA; POLYADENYLATED RNA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL DEATH; EMBRYO; GENE EXPRESSION; GENE MUTATION; GENE TARGETING; HISTOLOGY; LIVER CELL NUCLEUS; LIVER HYPERPLASIA; LYMPHOCYTOPOIESIS; LYMPHOID HYPERPLASIA; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEFICIENCY; STEM CELL; THYMOCYTE;

ANIMAL; ANTIGENS, CD95; APOPTOSIS; BASE SEQUENCE; EMBRYO; GENE EXPRESSION REGULATION; GENE TARGETING; HYPERPLASIA; LIVER; LYMPH NODES; MICE; MICE, INBRED BALB C; MICE, TRANSGENIC; MOLECULAR SEQUENCE DATA; MUTATION; SPLEEN; STEM CELLS; SUPPORT, NON-U.S. GOV'T;

EID: 0028856130     PISSN: 10614036     EISSN: 15461718     Source Type: Journal    
DOI: 10.1038/ng1195-294     Document Type: Article

References (50)

1. Ellis, R.E., Yuan, J. & Horvitz, H.R. Mechanisms and functions of cell death. Annu. Rev. Cell Biol. 7, 663-698 (1991).
2. Raff, M.C. Social controls on cell survival and cell death. Nature 356, 397-400 (1992).
3. Itoh, N. et al. The polypeptide encoded by the cDNA for human cell surface antigen Fas can mediate apoptosis. Cell 66, 233-243 (1991).
4. Oehm, A. et al. Purification and molecular cloning of the APO-1 cell surface antigen, a member of the tumor necrosis factor/nerve growth factor receptor superfamily: sequence identity with the Fas antigen. J. biol. Chem. 267, 10709-10715 (1992).
5. Watanabe-Fukunaga, R. et al. The cDNA structure, expression, and chromosomal assignment of the mouse Fas antigen. J. Immunol. 148, 1274-1279 (1992).
6. Suda, T., Takahashi, T., Golstein, R. & Nagata, S. Molecular cloning and expression of the Fas ligand: a novel member of the tumor necrosis factor family. Cell 75, 1169-1178 (1993).
7. Yonehara, S., Ishii, A. & Yonehara, M. A cell-killing monoclonal antibody (anti-Fas) to a cell surface antigen co-downregulated with the receptor of tumor necrosis factor. J. exp. Med.169, 1747-1756 (1989).
8. Trauth, B.C. et al. Monoclonal antibody-mediated tumor regression by induction of apoptosis. Science 245, 301-305 (1989).
9. Suda, T. et al. Expression of the Fas ligand in T-cell-lineage. J. Immunol. 154, 3806-3813 (1995).
10. Vignaux, F. et al. TCR/CD3 coupling to Fas-based cytotoxicity. J. exp. Med. 181, 781-786 (1995).
11. Kägi, D. et al. Fas and perforin pathway as major mechanisms of T cell-mediated cytotoxicity. Science 265, 528-530 (1994).
12. Lowin, B., Hahne, M., Mattmann, C. & Tschopp, J. T-cell cytotoxicity is mediated through perforin and Fas lytic pathways. Nature 370, 650-652 (1994).
13. 2+− independent T cell-mediated cytotoxicity. J. exp. Med. 177, 195-200 (1993).
14. Alderson, M.R. et al. Fas ligand mediates activation-induced cell death in human T lymphocytes. J. exp. Med. 181, 71-77 (1995).
15. Ju, S.-T. et al. Fas (CD95)/FasL interaction required for programmed cell death after T-cell activation. Nature 373, 444-448 (1995).
16. Russell, J.H., Rush, B., Weaver, C. & Wang, R. Mature T cells of autoimmune Ipr/lprmice have a defect in antigen-stimulated suicide. Proc. natn. Acad. Sci. U.S.A. 90, 4409-4413 (1993).
17. Singer, G.G. & Abbas, A.K., Fas antigen is involved in peripheral but not thymic deletion of T lymphocytes in T cell receptor transgenic mice. Immunity 1, 365-371 (1994).
18. Nagata, S. & Suda, T. Fas and Fas ligand: Ipr and gld mutations. Immunol. Today 16, 39-43 (1995).
19. Nagata, S. & Golstein, P., Fas death factor. Science 267, 1449-1456 (1995).
20. Adachi, M., Watanabe-Fukunaga, R. & Nagata, S. Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of Ipr mice.Proc. natn. Acad. Sci. U.S.A. 90, 1756-1760 (1993).
21. Kobayashi, S., Hirano, T., Kakinuma, M. & Uede, T. Transcriptional repression and differential splicing of Fas mRNA by early transposon (ETn) insertion in autoimmune LPRmice. Biochem. biophys. Res. Commun. 191, 617-624 (1993).
22. Chu, B.J.-L., Drappa, J., Parnassa, A. & Elkon, K.B. The defect in Fas mRNA expression in MRL/Ipr mice is associated with insertion of the retrotransposon, ETn. J. exp. Med. 178, 723-730 (1993).
23. Wu, J., Zhou, T., He, J. & Mountz, J.D. Autoimmune disease in mice due to integration of an endogenous retrovirus in an apoptosis gene. J. exp. Med. 178, 461-468 (1993).
24. Watanabe-Fukunaga, R., Brannan, C.I., Copeland, N.G., Jenkins, N.A. & Nagata, S. Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356, 314-317 (1992).
25. Takahashi, T. et al. Generalized lymphoproliferative disease in mice, caused by a point mutation in the Fas ligand. Cell 76, 969-976 (1994).
26. Mariani, S.M., Matiba, B., Armandola, E.A. & Krammer, R.H., APO-1/Fas (CD95) receptor is expressed in homozygous MRL/lpr mice. Eur. J. Immunol. 24, 3119-3123 (1994).
27. Cohen, R.L. & Eisenberg, R.A. Lpr and gld: single gene models of systemic autoimmunity and lymphoproliferative disease. Annu. Rev. Immunol. 9, 243-269 (1991).
28. Ni, R. et al. Fas-mediated apoptosis in primary cultured mouse hepatocytes. Exp. Cell Res.215, 332-337 (1995).
29. Ogasawara, J. et al. Lethal effect of the anti-Fas antibody in mice. Nature 364, 806-809 (1993).
30. Itoh, N. & Nagata, S. A novel protein domain required for apoptosis: mutational analysis of human Fas antigen. J. biol. Chem. 268, 10932-10937 (1993).
31. Yagi, T. et al. A novel negative selection for homologous recombinants using diphtheria toxin A fragment gene. Anal. Biochem. 214, 77-86 (1993).
32. Izui, S. et al. Induction of various autoantibodies by mutant gene Ipr in several strains of mice. J. Immunol. 133, 227-233 (1984).
33. + thymocytes by the anti-Fas antibody. J. exp. Med. 181, 485-491 (1995).
34. Tanaka, M., Suda, T., Takahashi, T. & Nagata, S. Expression of the functional soluble form of human Fas ligand in activated lymphocytes. EMBO J. 14, 1129-1135 (1995).
35. Benedetti, A., Jezequel, A.M. & Orlandi, F. Preferential distribution of apoptotic bodies in acinar zone 3 of normal human and rat liver. J. Hepatol. 7, 319-324 (1988).
36. Benedetti, A., Jezequel, A.M. & Orlandi, F. A quantitative evaluation of apoptotic bodies in rat liver. Liver 8, 172-177 (1988).
37. Arber, N., Zajicek, G. & Ariel, I. The streaming liver II. Hepatocyte life history. Liver 8, 80-87 (1988).
38. Andrew, W., Brown, H.M. & Johnson, J.B. Senile changes in the liver of mouse and man.Am. J. Anat. 72, 199-221 (1943).
39. Epstain, C.J. & Andrew, W. Nuclear ploidy in mammalian parenchyma! liver cells. Nature214, 1050-1051 (1967).
40. McWhir, J., Selfridge, J., Harrison, D.J., Squires, S. & Melton, D.W. Mice with DNA repair gene (ERCC-1) deficiency have elevated levels of p53, liver nuclear abnormalities and die before weaning. Alaftlre Genet. 5, 217-224 (1993).
41. Fisher, G.H. et al. Dominant interfering Fas gene mutations impair apoptosis in a human autoimmune lymphoproliferative syndrome. Cell 81, 935-946 (1995).
42. Rieux-Laucat, F. et al. Mutations in Fas associated with human lymphoproliferative syndrome and autoimmunity. Science 268, 1347-1349 (1995).
43. Tanaka, T. et al. Targeted disruption of the NF-IL6 gene discloses its essential role in bacteria killing and tumor cytotoxicity by macrophages. Cell 353-361 (1995).
44. Friedrich, G. & Soriano, P. Promoter traps in embryonic stem cells: a genetic screen to identify and mutate developmental genes in mice. Genes Dev. 5, 1513-1523 (1991).
45. Palmiter, R.D. et al. Cell lineage ablation in transgenic mice by cell-specific expression of a toxin gene. Cell 50, 435-443 (1987).
46. Mansour, S.L., Thomas, K.R. & Capecchi, M.R. Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes. Nature 336, 348-352 (1988).
47. MacMahon, A.R. & Bradley, A., The Wnt-1 (int-1) proto-oncogene is required for development of a large region of the mouse brain. Cell 62, 1037-1058 (1990).
48. Laird, R.W. et al. Simplified mammalian DNA isolation procedure. Nucl. Acids. Res. 19, 4293 (1991).
49. Ando, K. et al. Mechanisms of class I restricted immunopathology. A transgenic mouse model of fulminant hepatitis. J. exp. Med. 178, 1541-1554 (1993).
50. Watanabe, T., Katsura, Y., Yoshitake, A., Masataki, H. & Mori, T. IPAP: Image processor for analytical pathology. J. Toxicol. Pathol. 7, 353-361 (1994).